France Sticks to Plan to Give Johnson & Johnson Vaccine to Over-55s

By
vipulpatil40
-
0
35


This picture offered by Johnson & Johnson exhibits a vial of the COVID-19 vaccine. (AP)

That plan appeared to be in jeopardy after Johnson & Johnson stated Tuesday it might delay rollout of the vaccine in Europe after it was suspended within the US.

  • AFP Paris
  • Last Updated:April 14, 2021, 19:00 IST
  • FOLLOW US ON:

France is sticking to its plan to give over-55s the Johnson & Johnson vaccine suspended within the US and South Africa over uncommon blood clots, a authorities spokesman stated Wednesday.

Gabriel Attal additionally reaffirmed the federal government’s confidence within the AstraZeneca jab as an “essential tool” within the battle in opposition to Covid-19, hours after Denmark stated it was stopping its use, additionally over uncommon incidents of clots in individuals who acquired the vaccine.

France has already been utilizing the AstraZeneca jab amongst over-55s and had been planning to increase its marketing campaign with the Johnson & Johnson vaccine, which is analogous to the AstraZeneca shot.

That plan appeared to be in jeopardy after Johnson & Johnson stated Tuesday it might delay rollout of the vaccine in Europe after it was suspended within the US.

But Attal stated the federal government had acquired a primary supply of 200,000 doses, which “arrived on our territory at the start of the week and are being delivered to GPs and pharmacies”.

His remarks got here as EU chief Ursula von der Leyen warned the bloc was turning extra closely to BioNTech/Pfizer to make up for suspended Johnson & Johnson vaccine doses and for the long run.

Her remarks got here as increasingly more EU international locations restrict the usage of the adenovirus-type vaccines produced by AstraZeneca and Johnson & Johnson to older individuals, who’ve but to be affected by the clotting difficulty.

Denmark on Wednesday turned the primary EU nation to abandon the AstraZeneca vaccine altogether, regardless of the World Health Organization and European Medicines Agency deeming it protected.

Reacting to the Danish transfer, Attal stated: “We have confidence in the AstraZeneca vaccine as an essential tool in the fight against the Covid-19 epidemic.

”It is vital that this vaccine proceed to be deployed. It is a vaccine that’s protected and works.”

Read all of the Latest News and Breaking News right here





Source hyperlink